SYBX logo

Synlogic (SYBX) Stock

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

30 September 2015

Indexes:

Not included

Description:

SYBX, also known as Synlogic, is a biotechnology company focused on developing innovative therapies using synthetic biology. They create engineered bacteria to treat diseases by restoring normal biological functions. Their goal is to improve patient health through advanced, targeted treatments.

Key Details

Price

$1.44

Annual Revenue

$3.37 M(+185.68% YoY)

Annual EPS

-$8.81(+36.30% YoY)

Annual ROE

-91.46%

Beta

-0.17

Events Calendar

Earnings

Next earnings date:

Mar 19, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 19, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Sept 28, 2023

Analyst ratings

Recent major analysts updates

20 Mar '24 HC Wainwright & Co.
Neutral
09 Feb '24 Leerink Partners
Market Perform
09 Feb '24 HC Wainwright & Co.
Sell
09 Feb '24 Chardan Capital
Neutral
11 Dec '23 Alliance Global Partners
Buy
11 Aug '23 HC Wainwright & Co.
Buy
11 Aug '23 Chardan Capital
Buy
11 July '23 HC Wainwright & Co.
Buy
06 June '23 HC Wainwright & Co.
Buy
06 June '23 Chardan Capital
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Synlogic Reports Third Quarter 2024 Financial Results
Synlogic Reports Third Quarter 2024 Financial Results
Synlogic Reports Third Quarter 2024 Financial Results
SYBX
globenewswire.com12 November 2024

WINCHESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported financial results for the third quarter 2024 and provided a corporate update.

Synlogic, Inc. (SYBX) Reports Q4 Loss, Tops Revenue Estimates
Synlogic, Inc. (SYBX) Reports Q4 Loss, Tops Revenue Estimates
Synlogic, Inc. (SYBX) Reports Q4 Loss, Tops Revenue Estimates
SYBX
Zacks Investment Research19 March 2024

Synlogic, Inc. (SYBX) came out with a quarterly loss of $1.71 per share versus the Zacks Consensus Estimate of a loss of $1.11. This compares to loss of $3.60 per share a year ago.

Why Is Synlogic (SYBX) Stock Down 55% Today?
Why Is Synlogic (SYBX) Stock Down 55% Today?
Why Is Synlogic (SYBX) Stock Down 55% Today?
SYBX
InvestorPlace09 February 2024

Synlogic (NASDAQ: SYBX ) stock is falling on Friday after the clinical-stage biopharmaceutical company announced the discontinuation of its Synpheny-3 clinical trial. According to a press release from Synlogic, this decision comes after an internal review of the clinical trial's progress.

Why Is Synlogic (SYBX) Stock Down 6% Today?
Why Is Synlogic (SYBX) Stock Down 6% Today?
Why Is Synlogic (SYBX) Stock Down 6% Today?
SYBX
InvestorPlace28 September 2023

Synlogic (NASDAQ: SYBX ) stock is sliding lower on Thursday after the biopharmaceutical company announced a reverse split for its shares. According to a press release from Synlogic, the company enacted a reverse stock split after markets closed yesterday.

Synlogic to Present at the Jefferies Global Healthcare Conference
Synlogic to Present at the Jefferies Global Healthcare Conference
Synlogic to Present at the Jefferies Global Healthcare Conference
SYBX
GlobeNewsWire23 May 2023

CAMBRIDGE, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced that Aoife Brennan, M.B. Ch.B., President and Chief Executive Officer, will present at the Jefferies Global Healthcare Conference being held in New York, NY, June 7-9, 2023.

Synlogic, Inc. (SYBX) Reports Q4 Loss, Misses Revenue Estimates
Synlogic, Inc. (SYBX) Reports Q4 Loss, Misses Revenue Estimates
Synlogic, Inc. (SYBX) Reports Q4 Loss, Misses Revenue Estimates
SYBX
Zacks Investment Research29 March 2023

Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of 7.69% and 73.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

FAQ

  • What is the primary business of Synlogic?
  • What is the ticker symbol for Synlogic?
  • Does Synlogic pay dividends?
  • What sector is Synlogic in?
  • What industry is Synlogic in?
  • What country is Synlogic based in?
  • When did Synlogic go public?
  • Is Synlogic in the S&P 500?
  • Is Synlogic in the NASDAQ 100?
  • Is Synlogic in the Dow Jones?
  • When was Synlogic's last earnings report?
  • When does Synlogic report earnings?
  • Should I buy Synlogic stock now?

What is the primary business of Synlogic?

SYBX, also known as Synlogic, is a biotechnology company focused on developing innovative therapies using synthetic biology. They create engineered bacteria to treat diseases by restoring normal biological functions. Their goal is to improve patient health through advanced, targeted treatments.

What is the ticker symbol for Synlogic?

The ticker symbol for Synlogic is NASDAQ:SYBX

Does Synlogic pay dividends?

No, Synlogic does not pay dividends

What sector is Synlogic in?

Synlogic is in the Healthcare sector

What industry is Synlogic in?

Synlogic is in the Biotechnology industry

What country is Synlogic based in?

Synlogic is headquartered in United States

When did Synlogic go public?

Synlogic's initial public offering (IPO) was on 30 September 2015

Is Synlogic in the S&P 500?

No, Synlogic is not included in the S&P 500 index

Is Synlogic in the NASDAQ 100?

No, Synlogic is not included in the NASDAQ 100 index

Is Synlogic in the Dow Jones?

No, Synlogic is not included in the Dow Jones index

When was Synlogic's last earnings report?

Synlogic's most recent earnings report was on 12 November 2024

When does Synlogic report earnings?

The next expected earnings date for Synlogic is 19 March 2025

Should I buy Synlogic stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions